Skip to main content
. 2022 Jan 3;24:340–354. doi: 10.1016/j.omto.2021.12.025

Figure 1.

Figure 1

The prediction of antitumor targets of Nar by CMAP-DARTS/MS strategy

(A) The query genes of Nar were submitted to the CMAP database for analysis. (B) The top 20 drugs/agents that were positively correlated with Nar by the CMAP analysis. (C) Following DARTS assay, the samples were subjected to LC-MS/MS for proteomic analysis, and the possible Nar binding proteins were obtained. (D) The KEGG pathway was performed to analysis these potential binding proteins of Nar.